These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30167535)

  • 1. Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation.
    Trankle C; Thurber CJ; Toldo S; Abbate A
    JACC Basic Transl Sci; 2016 Oct; 1(6):524-535. PubMed ID: 30167535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cyclosporine in the treatment of myocardial reperfusion injury.
    Gill RS; Bigam DL; Cheung PY
    Shock; 2012 Apr; 37(4):341-7. PubMed ID: 22293599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
    Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
    Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
    Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
    Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cyclosporine A use in the prevention of reperfusion injury in acute myocardial infarction: A meta-analysis.
    Upadhaya S; Madala S; Baniya R; Subedi SK; Saginala K; Bachuwa G
    Cardiol J; 2017; 24(1):43-50. PubMed ID: 27734457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
    Hausenloy DJ; Yellon DM
    Heart Fail Rev; 2007 Dec; 12(3-4):217-34. PubMed ID: 17541822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
    Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
    Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
    Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
    Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore.
    Dorsch M; Behmenburg F; Raible M; Blase D; Grievink H; Hollmann MW; Heinen A; Huhn R
    PLoS One; 2016; 11(3):e0151025. PubMed ID: 26968004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of mitochondrial permeability transition pore inhibitors.
    Naryzhnaya NV; Maslov LN; Oeltgen PR
    Drug Dev Res; 2019 Dec; 80(8):1013-1030. PubMed ID: 31823411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition.
    Leshnower BG; Kanemoto S; Matsubara M; Sakamoto H; Hinmon R; Gorman JH; Gorman RC
    Ann Thorac Surg; 2008 Oct; 86(4):1286-92. PubMed ID: 18805178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology of Myocardial Ischemia and Reperfusion Injury: Models, Modes, Molecular Mechanisms, Modulation, and Clinical Applications.
    Buja LM
    Cardiol Rev; 2023 Sep-Oct 01; 31(5):252-264. PubMed ID: 35175958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of mitochondrial-mediated cardiomyocytes injury in acute myocardial infarction with cardiogenic shock].
    Xiao W; Jiang Y; Zou L; Chen F; Gu X; Liu X; Zhu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jul; 32(7):885-889. PubMed ID: 32788031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
    Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
    Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial pathways, permeability transition pore, and redox signaling in cardioprotection: therapeutic implications.
    Penna C; Perrelli MG; Pagliaro P
    Antioxid Redox Signal; 2013 Feb; 18(5):556-99. PubMed ID: 22668069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-treatment of a single high-dose of atorvastatin provided cardioprotection in different ischaemia/reperfusion models via activating mitochondrial KATP channel.
    Zhao Z; Cui W; Zhang H; Gao H; Li X; Wang Y; Hu H; Li B
    Eur J Pharmacol; 2015 Mar; 751():89-98. PubMed ID: 25641746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic Role of mPTP in Ischemia-Reperfusion Injury.
    Morciano G; Bonora M; Campo G; Aquila G; Rizzo P; Giorgi C; Wieckowski MR; Pinton P
    Adv Exp Med Biol; 2017; 982():169-189. PubMed ID: 28551787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is further improvement of the treatment of acute coronary syndromes still possible?
    Dąbrowski MJ
    Postepy Kardiol Interwencyjnej; 2013; 9(1):41-4. PubMed ID: 24570690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.